CORDIS · 641725 · H2020
PHEBE New paradigms for high efficiency blue emitters for white OLEDS
Coordinator: INTELLIGENTSIA CONSULTANTS SARL (LU)
The overall objective of the PHEBE project is to develop innovative, high-efficiency, blue emitters for white OLEDS, which will create a major breakthrough in the cost performance of OLED lighting. To produce the innovative blue emitters, two new types of molecular systems – without rare earth complexes - will be investigated: • intramolecular charge transfer systems that enable thermally activated delayed fluorescence (ICT-TADF)• intermolecular exciplex charge transfer systems that enable thermally activated delayed fluorescence (Exciplex-TADF)In order to develop the ICT-TADF and Exciplex-TA…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €3.9M awarded to the consortium. The project runs over approximately 3.5 years from 2015-02-01 to 2018-07-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from LU
see all →- HEDGE-IoT — Holistic Approach towards Empowerment of the DiGitalization of the Energy Ecosystem through adoption of IoT solutions101136216 · HORIZON · €18.0M
- DESIDERATA — Integrated Pathways: Advancing Safe and Sustainable by Design Material Innovation through Collaborative Wisdom101178011 · HORIZON · €10.7M
- TrustChain — Fostering a Human-Centered, Trustworthy and Sustainable Internet101093274 · HORIZON · €10.6M
- HealthyW8 — Empowering healthy lifestyle behaviour through personalised intervention portfolios to prevent and control obesity during vulnerable stages of life101080645 · HORIZON · €10.0M
- PATH — Patient AI Treatment Hub101253520 · HORIZON · €8.9M
- ALCEMIST — Atypical Liquid Crystal Elastomers: from Materials Innovation to Scalable processing and Transformative applications101167171 · HORIZON · €8.5M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the RIA funding scheme.
- What is the EU contribution?
- The European Commission contributes €3.9M toward a total project budget of €3.9M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-ICT-2014.
- Who coordinates the project?
- The project is coordinated by INTELLIGENTSIA CONSULTANTS SARL (LU).
- What is the project timeline?
- The project runs from 2015-02-01 to 2018-07-31 — approximately 3.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 641725.